Pyridoxine is the 4-methanol form of vitamin B6, an important water-soluble vitamin that is naturally present in many foods. As its classification as a vitamin implies, Vitamin B6 (and pyridoxine) are essential nutrients required for normal functioning of many biological systems within the body. While many plants and microorganisms are able to synthesize pyridoxine through endogenous biological processes, animals must obtain it through their diet.
More specifically, pyridoxine is converted to pyridoxal 5-phosphate in the body, which is an important coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, and aminolevulinic acid. It's important to note that Vitamin B6 is the collective term for a group of three related compounds, pyridoxine, pyridoxal, and pyridoxamine, and their phosphorylated derivatives, pyridoxine 5'-phosphate, pyridoxal 5'-phosphate and pyridoxamine 5'-phosphate. Although all six of these compounds should technically be referred to as vitamin B6, the term vitamin B6 is commonly used interchangeably with just one of them, pyridoxine .
Vitamin B6, principally in its biologically active coenzyme form pyridoxal 5'-phosphate, is involved in a wide range of biochemical reactions, including the metabolism of amino acids and glycogen, the synthesis of nucleic acids, hemogloblin, sphingomyelin and other sphingolipids, and the synthesis of the neurotransmitters serotonin, dopamine, norepinephrine and gamma-aminobutyric acid (GABA) .
Pyridoxine is used medically for the treatment of vitamin B6 deficiency and for the prophylaxis of isoniazid-induced peripheral neuropathy (due to Isoniazid's mechanism of action which competitively inhibits the action of pyridoxine in the above-mentioned metabolic functions). It is also used in combination with Doxylamine (as the commercially available product Diclectin) for the treatment of nausea and vomiting in pregnancy.
Pyridoxine is indicated for the treatment of vitamin B6 deficiency and for the prophylaxis of Isoniazid-induced peripheral neuropathy. It is also approved by Health Canada for the treatment of nausea and vomiting in pregnancy in a combination product with Doxylamine (as the commercially available product Diclectin).
Women's Health Centre, Eastern Health, St. John's, Newfoundland and Labrador, Canada
Obstetrics and Gynecology Associates, Dartmouth, Nova Scotia, Canada
Beersheva Mental Health Center, Beersheva, Israel
Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine, Los Angeles, California, United States
Georgetown University, Washington, DC, District of Columbia, United States
Mayo Clinic, Scottsdale, Scottsdale, Arizona, United States
Southern Illinois University, Springfield, Illinois, United States
Montefiore Drug Treatment Ctr / Bronx Municipal Hosp, Bronx, New York, United States
Cook County Hosp, Chicago, Illinois, United States
Bronx Lebanon Hosp Ctr, Bronx, New York, United States
AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States
Philadelphia FIGHT, Philadelphia, Pennsylvania, United States
Boston Dept of Health and Hosps, Boston, Massachusetts, United States
Moses H Cone Memorial Hosp, Greensboro, North Carolina, United States
State of MD Div of Corrections / Johns Hopkins Univ Hosp, Baltimore, Maryland, United States
Johns Hopkins Hosp, Baltimore, Maryland, United States
Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States
Univ. of Miami AIDS CRS, Miami, Florida, United States
Cook County Hosp. CORE Ctr., Chicago, Illinois, United States
Comprehensive AIDS Alliance of Detroit, Detroit, Michigan, United States
Clinical Directors Network of Region II, New York, New York, United States
Denver CPCRA / Denver Public Hlth, Denver, Colorado, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.